Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 23095621)

1.

A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSurvey-based study.

Andres A, Toso C, Adam R, Barroso E, Hubert C, Capussotti L, Gerstel E, Roth A, Majno PE, Mentha G.

Ann Surg. 2012 Nov;256(5):772-8; discussion 778-9. doi: 10.1097/SLA.0b013e3182734423.

PMID:
23095621
2.

The prognostic value of the primary tumor’s nodal status after surgery for colorectal liver metastases in the era of effective systemic therapy.

van der Stok EP, Grünhagen DJ, Alberda WJ, Reitsma M, Rothbarth J, Verhoef C.

Dig Surg. 2015;32(3):208-16.

PMID:
25896431
3.

Preliminary results of 'liver-first' reverse management for advanced and aggressive synchronous colorectal liver metastases: a propensity-matched analysis.

Tanaka K, Murakami T, Matsuo K, Hiroshima Y, Endo I, Ichikawa Y, Taguri M, Koda K.

Dig Surg. 2015;32(1):16-22. doi: 10.1159/000370253. Epub 2015 Jan 22.

PMID:
25613745
4.

The clinical relevance of the Fong and the Nordlinger scores in the era of effective neoadjuvant chemotherapy for colorectal liver metastasis.

Schreckenbach T, Malkomes P, Bechstein WO, Woeste G, Schnitzbauer AA, Ulrich F.

Surg Today. 2015 Jan 7. [Epub ahead of print]

PMID:
25563588
5.

Evidence-based integration of selective internal radiation therapy in the management of colorectal liver metastases.

Wasan HS.

Future Oncol. 2014 Nov;10(15 Suppl):33-6. doi: 10.2217/fon.14.220. No abstract available.

PMID:
25478764
6.

Use of Pharmacologic Agents for Modulation of Ischaemia-Reperfusion Injury after Hepatectomy: A Questionnaire Study of the LiverMetSurvey International Registry of Hepatic Surgery Units.

Jegatheeswaran S, Jamdar S, Satyadas T, Sheen AJ, Adam R, Siriwardena AK.

HPB Surg. 2014;2014:437159. doi: 10.1155/2014/437159. Epub 2014 Nov 12.

7.

Up front hepatectomy for metastatic rectal carcinoma - reversed, liver first approach. Early experience with 15 patients.

Straka M, Skrovina M, Soumarova R, Kotasek R, Burda L, Vojtek C.

Neoplasma. 2014;61(4):447-52.

PMID:
25027742
8.

Impact of peri-operative bevacizumab on survival in patients with resected colorectal liver metastases: an analysis of the LiverMetSurvey.

Rong Z, Martel G, Vandenbroucke-Menu F, Adam R, Lapointe R.

HPB (Oxford). 2014 Apr;16(4):342-9. doi: 10.1111/hpb.12138.

9.

[Colorectal cancer - review].

Haraldsdottir S, Einarsdottir HM, Smaradottir A, Gunnlaugsson A, Halfdanarson TR.

Laeknabladid. 2014 Feb;100(2):75-82. Review. Icelandic.

PMID:
24639430
10.

Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.

Zhu D, Zhong Y, Wei Y, Ye L, Lin Q, Ren L, Ye Q, Liu T, Xu J, Qin X.

PLoS One. 2014 Jan 21;9(1):e86543. doi: 10.1371/journal.pone.0086543. eCollection 2014.

11.

[Conversion therapy for synchronous colorectal liver metastases].

Morohashi H, Yokoyama H, Akasaka H, Sakamoto Y, Koyama M, Murata A, Hakamada K.

Gan To Kagaku Ryoho. 2013 Nov;40(12):1665-7. Japanese.

PMID:
24393882
12.

Occurrence and survival of synchronous pulmonary metastases in colorectal cancer: a nationwide cohort study.

Nordholm-Carstensen A, Krarup PM, Jorgensen LN, Wille-Jørgensen PA, Harling H; Danish Colorectal Cancer Group.

Eur J Cancer. 2014 Jan;50(2):447-56. doi: 10.1016/j.ejca.2013.10.009. Epub 2013 Nov 8.

PMID:
24215844
13.

Palliative surgery in patients with unresectable colorectal liver metastases: a propensity score matching analysis.

Yoon YS, Kim CW, Lim SB, Yu CS, Kim SY, Kim TW, Kim MJ, Kim JC.

J Surg Oncol. 2014 Mar;109(3):239-44. doi: 10.1002/jso.23480. Epub 2013 Oct 25.

PMID:
24165972
14.

Stage IV colorectal cancer: outcomes following the liver-first approach.

de Rosa A, Gomez D, Hossaini S, Duke K, Fenwick SW, Brooks A, Poston GJ, Malik HZ, Cameron IC.

J Surg Oncol. 2013 Dec;108(7):444-9. doi: 10.1002/jso.23429. Epub 2013 Sep 5.

PMID:
24009161
15.

Modern chemotherapy mitigates adverse prognostic effect of regional nodal metastases in stage IV colorectal cancer.

Thomay AA, Nagorney DM, Cohen SJ, Sigurdson ER, Truty MJ, Burtness B, Hall MJ, Chun YS.

J Gastrointest Surg. 2014 Jan;18(1):69-74. doi: 10.1007/s11605-013-2329-8. Epub 2013 Sep 4.

PMID:
24002765
16.

Evaluation of prognostic factors in liver-limited metastatic colorectal cancer: a preplanned analysis of the FIRE-1 trial.

Giessen C, Fischer von Weikersthal L, Laubender RP, Stintzing S, Modest DP, Schalhorn A, Schulz C, Heinemann V.

Br J Cancer. 2013 Sep 17;109(6):1428-36. doi: 10.1038/bjc.2013.475. Epub 2013 Aug 20.

17.

The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systematic review.

Jegatheeswaran S, Mason JM, Hancock HC, Siriwardena AK.

JAMA Surg. 2013 Apr;148(4):385-91. doi: 10.1001/jamasurg.2013.1216. Review.

PMID:
23715907
18.

Magnetic resonance imaging flowmetry demonstrates portal vein dilatation subsequent to oxaliplatin therapy in patients with colorectal liver metastasis.

Urdzik J, Bjerner T, Wanders A, Duraj F, Haglund U, Norén A.

HPB (Oxford). 2013 Apr;15(4):265-72. doi: 10.1111/j.1477-2574.2012.00540.x. Epub 2012 Aug 20.

19.

The effect of hepatic steatosis on survival following resection of colorectal liver metastases in patients without preoperative chemotherapy.

Parkin E, O'Reilly DA, Adam R, Kaiser GM, Laurent C, Elias D, Capussotti L, Renehan AG; LiverMetSurvey Centres.

HPB (Oxford). 2013 Jun;15(6):463-72. doi: 10.1111/hpb.12007. Epub 2012 Dec 27.

20.

Colorectal cancer metastases: a surgical perspective.

Sugarbaker PH.

Surg Oncol Clin N Am. 2013 Apr;22(2):289-98. doi: 10.1016/j.soc.2012.12.007. Epub 2013 Jan 2. Review.

PMID:
23453335
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk